View Exam | PowerPak

1. According to the CHAMP-HF registry, frequent hospital admissions and poor health-related quality of life in patients with HFrEF are due to:

A. suboptimal use of combination therapy B. suboptimal use of evidence-based therapies as recommended in current guidelines C. poor lifestyle behaviors D. suboptimal treatment of associated comorbidities such as hypertension and diabetes mellitus E. Unsure

2. The 2017 Expert Consensus Decision Pathway for Optimization of Heart Failure Treatment: Answers to 10 Pivotal Issues About Heart Failure With Reduced Ejection Fraction identified 10 pivotal issues to:

A. promote earlier identification of patients at risk for heart failure B. reduce medical and surgical errors C. optimize pharmacotherapy D. address barriers in healthcare system delivery and payer practices E. Unsure

3. The 4 key recommendations advanced by the American College of Clinical Pharmacy, the Community Pharmacy Enhanced Services Network USA, and the National Community Pharmacists Association Innovation Center serve to:

A. facilitate collaboration among pharmacists in the community and clinic settings B. establish standards for pharmacists who wish to become credentialed in providing heart failure care C. establish reimbursement policies for care provided to patients with heart failure by pharmacists in different practice settings D. provide recommendations for pharmaceutical care for patients with heart failure E. Unsure

4. In conducting a mediation therapy review, a key point to keep in mind is:

A. Invite active involvement of the patient, as well as family and caregivers B. Conduct the review in a quiet private setting at a time scheduled in advance C. Create a database of information D. All of the above E. Unsure

5. When a barrier to treatment adherence is identified, the pharmacist should:

A. recommend to the prescriber that the treatment should be changed B. reinforce the importance of following the treatment plan previously developed C. find solutions in collaboration with the patient that the patient is willing and able to implement D. advise the patient that their behavior is negatively impacting their health E. Unsure

6. Which tool has been validated to assess adherence to oral medication for select chronic conditions?

A. The Adherence Risk Finder B. The Adherence Estimator C. The MedAdhere Tool D. The Medication Calculator E. Unsure

7. In 2017, the ACC published “Expert Consensus Decision Pathway for Optimization of Heart Failure Treatment: Answers to 10 Pivotal Issues About Heart Failure With Reduced Ejection Fraction.” According to the recommendations, what should a pharmacist do to monitor adherence and target patients at risk?

A. Ask the patient how many times a week they miss taking their medications B. Use a validated tool to assess adherence C. Ask the patient permission to review their smartphone M-Health applications D. Ask the patient to verbally list the heart failure medications they are taking and at what time of day E. Unsure

8. Fabbri et al recently conducted a survey to measure health literacy and its impact on health outcomes in patients with heart failure. Compared with patients with good health literacy, the study showed that the risk of all-cause mortality in patients was:

A. Similar B. 32% higher C. 91% higher D. 164% higher E. Unsure

9. Which one of the following is a screening tool for health literacy that can be used during the patient visit and takes less than 2 minutes?

A. Brief Health Literacy Screen B. Rapid Estimate of Adult Literacy in Medicine C. Short Assessment of Health Literacy D. Short Test of Functional Health Literacy in Adults E. Unsure

10. Which is an online or smartphone application that can be used by clinicians to help guide and optimize pharmacological therapy for patients with chronic stage C HFrEF?

A. HF Guide B. HF Path C. TreatHF D. None of the above E. Unsure

Maintenance is scheduled for 8/7/2023 7:00 AM EST - 8:00 AM EST.

{{recommendationsA.Title}}

{{recommendationsB.Title}}

1. According to the CHAMP-HF registry, frequent hospital admissions and poor health-related quality of life in patients with HFrEF are due to:

2. The 2017 Expert Consensus Decision Pathway for Optimization of Heart Failure Treatment: Answers to 10 Pivotal Issues About Heart Failure With Reduced Ejection Fraction identified 10 pivotal issues to:

3. The 4 key recommendations advanced by the American College of Clinical Pharmacy, the Community Pharmacy Enhanced Services Network USA, and the National Community Pharmacists Association Innovation Center serve to:

4. In conducting a mediation therapy review, a key point to keep in mind is:

5. When a barrier to treatment adherence is identified, the pharmacist should:

6. Which tool has been validated to assess adherence to oral medication for select chronic conditions?

8. Fabbri et al recently conducted a survey to measure health literacy and its impact on health outcomes in patients with heart failure. Compared with patients with good health literacy, the study showed that the risk of all-cause mortality in patients was:

9. Which one of the following is a screening tool for health literacy that can be used during the patient visit and takes less than 2 minutes?

10. Which is an online or smartphone application that can be used by clinicians to help guide and optimize pharmacological therapy for patients with chronic stage C HFrEF?

« Return to Activity

Maintenance is scheduled for 8/7/2023 7:00 AM EST - 8:00 AM EST.

The shopping cart is empty

Customers who Purchasedthis Activity also Purchased

{{recommendationsA.Title}}

{{recommendationsB.Title}}

1. According to the CHAMP-HF registry, frequent hospital admissions and poor health-related quality of life in patients with HFrEF are due to:

2. The 2017 Expert Consensus Decision Pathway for Optimization of Heart Failure Treatment: Answers to 10 Pivotal Issues About Heart Failure With Reduced Ejection Fraction identified 10 pivotal issues to:

3. The 4 key recommendations advanced by the American College of Clinical Pharmacy, the Community Pharmacy Enhanced Services Network USA, and the National Community Pharmacists Association Innovation Center serve to:

4. In conducting a mediation therapy review, a key point to keep in mind is:

5. When a barrier to treatment adherence is identified, the pharmacist should:

6. Which tool has been validated to assess adherence to oral medication for select chronic conditions?

8. Fabbri et al recently conducted a survey to measure health literacy and its impact on health outcomes in patients with heart failure. Compared with patients with good health literacy, the study showed that the risk of all-cause mortality in patients was:

9. Which one of the following is a screening tool for health literacy that can be used during the patient visit and takes less than 2 minutes?

10. Which is an online or smartphone application that can be used by clinicians to help guide and optimize pharmacological therapy for patients with chronic stage C HFrEF?

« Return to Activity

Customers who Purchased
this Activity also Purchased